Carisma Therapeutics Statistics

Total Valuation

CARM has a market cap or net worth of $17.45 million. The enterprise value is -$7.36 million.

Market Cap	17.45M
Enterprise Value	-7.36M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

CARM has 41.75 million shares outstanding. The number of shares has increased by 71.70% in one year.

Current Share Class	41.75M
Shares Outstanding	41.75M
Shares Change (YoY)	+71.70%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	12.24%
Owned by Institutions (%)	19.19%
Float	30.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
Forward PS	1.09
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.23

Current Ratio	3.23
Quick Ratio	2.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -362.79% and return on invested capital (ROIC) is -202.41%.

Return on Equity (ROE)	-362.79%
Return on Assets (ROA)	-56.08%
Return on Capital (ROIC)	-202.41%
Revenue Per Employee	$189,421
Profits Per Employee	-$596,262
Employee Count	107
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	-197,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-85.98%
50-Day Moving Average	0.85
200-Day Moving Average	1.25
Relative Strength Index (RSI)	18.32
Average Volume (20 Days)	361,384

Short Selling Information

The latest short interest is 554,174, so 1.33% of the outstanding shares have been sold short.

Short Interest	554,174
Short Previous Month	558,578
Short % of Shares Out	1.33%
Short % of Float	1.83%
Short Ratio (days to cover)	2.88

Income Statement

In the last 12 months, CARM had revenue of $20.27 million and -$63.80 million in losses. Loss per share was -$1.55.

Revenue	20.27M
Gross Profit	-43.24M
Operating Income	-66.77M
Pretax Income	-72.70M
Net Income	-63.80M
EBITDA	-63.37M
EBIT	-66.77M
Loss Per Share	-$1.55

Full Income Statement

Balance Sheet

The company has $28.13 million in cash and $3.32 million in debt, giving a net cash position of $24.81 million or $0.59 per share.

Cash & Cash Equivalents	28.13M
Total Debt	3.32M
Net Cash	24.81M
Net Cash Per Share	$0.59
Equity (Book Value)	-11.13M
Book Value Per Share	-0.27
Working Capital	23.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.66 million and capital expenditures -$684,000, giving a free cash flow of -$68.35 million.

Operating Cash Flow	-67.66M
Capital Expenditures	-684,000
Free Cash Flow	-68.35M
FCF Per Share	-$1.64

Full Cash Flow Statement

Margins

Gross Margin	-213.35%
Operating Margin	-329.46%
Pretax Margin	-315.75%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CARM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-71.70%
Shareholder Yield	-71.70%
Earnings Yield	-365.67%
FCF Yield	-391.73%

Dividend Details

Analyst Forecast

The average price target for CARM is $4.57, which is 993.56% higher than the current price. The consensus rating is "Hold".

Price Target	$4.57
Price Target Difference	993.56%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	58.36%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARM has an Altman Z-Score of -12.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.76
Piotroski F-Score	2